MELYSSA WIGGINS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MC LEANSBORO, IL NPI 1245798347

General Payments — all program years on this page

$1,046.59

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 67
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $269.90 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $269.9020

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $156.4113
Bayer HealthCare Pharmaceuticals Inc. $46.643
Lilly USA, LLC $38.252
Acerta Pharma LLC $14.381
Exact Sciences Corporation $14.221

By program year

Program yearAmountRecords
2021 $222.1614
2022 $174.8611
2023 $379.6722
2024 $269.9020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086271626 Bayer Healthcare Pharmaceuticals Inc. $15.88 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086305748 Bayer Healthcare Pharmaceuticals Inc. $15.35 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086342421 Bayer Healthcare Pharmaceuticals Inc. $15.41 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100225488 Novo Nordisk Inc $23.25 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100231712 Novo Nordisk Inc $16.34 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100237856 Novo Nordisk Inc $11.99 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100254542 Novo Nordisk Inc $13.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100354442 Novo Nordisk Inc $13.49 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100364423 Novo Nordisk Inc $9.40 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100381909 Novo Nordisk Inc $1.30 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100392478 Novo Nordisk Inc $14.39 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100419649 Novo Nordisk Inc $15.65 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100513329 Novo Nordisk Inc $13.48 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100522881 Novo Nordisk Inc $11.95 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100603750 Novo Nordisk Inc $11.74 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100637618 Novo Nordisk Inc $0.43 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104568076 AstraZeneca Pharmaceuticals LP $14.38 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114949561 Exact Sciences Corporation $14.22 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135830787 Lilly USA, LLC $18.71 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135830791 Lilly USA, LLC $19.54 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.